- Home
- SSP vs OABI Comparison
SSP vs OABI Comparison
Compare SSP & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSP
- OABI
- Stock Information
- Founded
- SSP 1878
- OABI 2012
- Country
- SSP United States
- OABI United States
- Employees
- SSP N/A
- OABI N/A
- Industry
- SSP Broadcasting
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- SSP Industrials
- OABI Health Care
- Exchange
- SSP Nasdaq
- OABI Nasdaq
- Market Cap
- SSP 225.2M
- OABI 227.4M
- IPO Year
- SSP 1988
- OABI N/A
- Fundamental
- Price
- SSP $2.27
- OABI $1.73
- Analyst Decision
- SSP Buy
- OABI Strong Buy
- Analyst Count
- SSP 2
- OABI 3
- Target Price
- SSP $5.50
- OABI $6.67
- AVG Volume (30 Days)
- SSP 511.9K
- OABI 555.0K
- Earning Date
- SSP 11-03-2025
- OABI 11-04-2025
- Dividend Yield
- SSP N/A
- OABI N/A
- EPS Growth
- SSP N/A
- OABI N/A
- EPS
- SSP 0.48
- OABI N/A
- Revenue
- SSP $2,439,152,000.00
- OABI $23,027,000.00
- Revenue This Year
- SSP N/A
- OABI N/A
- Revenue Next Year
- SSP $9.92
- OABI $48.74
- P/E Ratio
- SSP $4.53
- OABI N/A
- Revenue Growth
- SSP 5.25
- OABI 6.05
- 52 Week Low
- SSP $1.36
- OABI $1.22
- 52 Week High
- SSP $4.17
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- SSP 36.14
- OABI 54.17
- Support Level
- SSP $2.14
- OABI $1.64
- Resistance Level
- SSP $2.32
- OABI $1.80
- Average True Range (ATR)
- SSP 0.11
- OABI 0.10
- MACD
- SSP -0.01
- OABI 0.01
- Stochastic Oscillator
- SSP 27.37
- OABI 50.00
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.